We found that AST-120 treatment significantly reduced both the serum and brain levels of IS (Figure 4), ameliorated NLRP3 inflammasome-induced neuroinflammation in the hippocampus, and improved short-term and long-term memory impairment in CKD mice. This evidence concerns the gene NLRP3 and chronic kidney disease.